Improvement in bone manifestations and respiratory status in infants and young children with HPP treated with asfotase alfa: an update on the ENB-010-10 trial

2015 ◽  
Author(s):  
Christine Hofmann ◽  
Cheryl Rockman-Greenberg ◽  
Paul Harmatz ◽  
Scott Moseley ◽  
Tatjana Odrljin ◽  
...  
Keyword(s):  
Young Children ◽  
Asfotase Alfa ◽  
Respiratory Status ◽  
Infants And Young Children

scholarly journals Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial

2019 ◽  
Vol 7 (2) ◽  
pp. 93-105 ◽  
Author(s):  
Michael P Whyte ◽  
Jill H Simmons ◽  
Scott Moseley ◽  
Kenji P Fujita ◽  
Nicholas Bishop ◽  
...  
Keyword(s):  
Young Children ◽  
Phase 2 ◽  
Open Label ◽  
Asfotase Alfa ◽  
Open Label Phase ◽  
Extension Trial ◽  
Infants And Young Children

scholarly journals NT-pro BNP-A marker for worsening respiratory status and mortality in infants and young children with pulmonary hypertension

2018 ◽  
Vol 13 (4) ◽  
pp. 499-505 ◽  
Author(s):  
Shahnawaz M. Amdani ◽  
Muhammad Umair M. Mian ◽  
Ron L. Thomas ◽  
Robert D. Ross
Keyword(s):  
Pulmonary Hypertension ◽  
Young Children ◽  
Respiratory Status ◽  
Infants And Young Children

scholarly journals Efficacy and Safety of Asfotase Alfa in Infants and Young Children With Hypophosphatasia: A Phase 2 Open-Label Study

2019 ◽  
Vol 104 (7) ◽  
pp. 2735-2747 ◽  
Author(s):  
Christine E Hofmann ◽  
Paul Harmatz ◽  
Jerry Vockley ◽  
Wolfgang Högler ◽  
Hideki Nakayama ◽  
...  
Keyword(s):  
Young Children ◽  
Phase 2 ◽  
Efficacy And Safety ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Asfotase Alfa ◽  
Infants And Young Children
Sign in / Sign up

Export Citation Format

Share Document